TFA
GMAB icon

Transamerica Financial Advisors’s Genmab GMAB Stock Holding History

Transamerica Financial Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.57K Buy
239
+50
+26% +$1.33K ﹤0.01% 1070
2026
Q1 		$5.07K Buy
189
+37
+24% +$1.11K ﹤0.01% 1041
2025
Q4 		$4.68K Sell
152
-61
-29% -$1.9K ﹤0.01% 974
2025
Q3 		$6.53K Buy
+213
New +$5.19K ﹤0.01% 816

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Transamerica Financial Advisors's GMAB Position: Q2 2026 in Review

Transamerica Financial Advisors increased its Genmab (GMAB) stake by 26% in Q2 2026, buying an estimated $1.33K and bringing the position to 239 shares worth $6.57K. The position accounts for ﹤0.01% of the portfolio, ranked #1070.

Transamerica Financial Advisors first reported a position in GMAB in Q3 2025 and has held it in 4 quarters since. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Transamerica Financial Advisors held 239 shares of Genmab worth $6.57K as of Q2 2026.
  • Transamerica Financial Advisors bought 50 Genmab shares in Q2 2026, an estimated $1.33K.
  • Genmab made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #1070 holding.
  • Transamerica Financial Advisors first reported a position in Genmab in Q3 2025 and has held it in 4 quarters since.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.